Pebble Life Science

About

We Kill Cancer with Plants Existing standard cancer treatments sometimes reduce mortality but always with significant adverse effects. While there is high unmet need for complementary oncologic and neurologic therapies, expanding research on the cancer-killing properties of plant-based agents remains uncommercialized. Pebble is developing novel, non-psychotropic botanical agents with multiple mechanisms of action working in combination and clear regulatory pathways to commercialize innovative cancer therapies that at a minimum improve progression-free survival and overall response rate, beyond the current standard of care.